Mike Dombeck
Advisor
Chief Operating Officer, Arcellx, Clinical-Stage adaptable and controllable cell therapies for cancer and autoimmune diseases.
Prior roles:
- SVP Corporate Development, Precision Biosciences;
- R&D Director, GlaxoSmithKline;
- Deputy Director, Talecris Biotherapeutics;
- Executive, BD, Campbell Alliance and DarPharma;
- Co-Founder, Cempra Pharmaceuticals;
- Health Economist, RTI Health Solutions.